Search

Your search keyword '"Soto ‐ Ortolaza, A. I."' showing total 195 results

Search Constraints

Start Over You searched for: Author "Soto ‐ Ortolaza, A. I." Remove constraint Author: "Soto ‐ Ortolaza, A. I."
195 results on '"Soto ‐ Ortolaza, A. I."'

Search Results

1. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype

2. LRRK2 variation and dementia with Lewy bodies

3. MAPT haplotype diversity in multiple system atrophy

5. TARDBP mutations in Parkinson's disease

7. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

10. DNAJC13 p.Asn855Ser mutation screening in Parkinsonʼs disease and pathologically confirmed Lewy body disease patients

14. Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinsonʼs disease (GEO-PD) consortium

16. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimerʼs diseases

18. The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

20. Ataxin-2 repeat-length variation and neurodegeneration

21. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease

22. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinsonʼs disease

24. Association of α-, β-, and γ-Synuclein With Diffuse Lewy Body Disease

26. Calbindin-1 association and Parkinsonʼs disease

28. Study of LRRK2 variation in tauopathy: progressive supranuclear palsy and corticobasal degeneration

29. TREM2 p.R47H SUBSTITUTION IS NOT ASSOCIATED WITH DEMENTIA WITH LEWY BODIES

30. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

32. Genome-wide association study in essential tremor identifies three new loci

33. RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies

34. Identification of genetic modifiers of age-at-onset for familial Parkinson’s disease

35. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies

36. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium

37. Mitochondrial targeting sequence variants of theCHCHD2gene are a risk for Lewy body disorders

38. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies

39. Exonic Re-Sequencing of the Chromosome 2q24.3 Parkinson’s Disease Locus

40. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

42. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.

43. Analysis of COQ2gene in multiple system atrophy

44. LRRK2 exonic variants and risk of multiple system atrophy

45. VPS35 and DNAJC13 disease-causing variants in essential tremor

46. SLC1A2 rs3794087 does not associate with essential tremor

47. Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

48. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

49. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

50. NOTCH3 Variants and Risk of Ischemic Stroke

Catalog

Books, media, physical & digital resources